Lung function in patients with congenital heart diseases

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021120

Enrollment

1000

Registered

2020-03-20

Start date

2019-04-08

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Q20-Q28

Interventions

Group 1: Potential patients will be contacted as part of their appointment at the outpatient clinic for congenital heart defects at the German Heart Center Munich. This is followed by information on d

haemodynamics: duration/extent of pulmonary hypercirculation [Qp/Qs]

operations: number, age, access route

cyanosis: duration, extent • Other sporting abilities (fitness gram): strength and flexibility • Lifestyle: smoking, daily physical a

Eligibility

Sex/Gender

All

Age

8 Years to No maximum

Inclusion criteria

Inclusion criteria: Congenital heart disease

Exclusion criteria

Exclusion criteria: Cognitive impairment, which makes it impossible to perform body plethysmography.

Design outcomes

Primary

Measure	Time frame
• Are there changes in lung function in patients with congenital heart defects? • Are there differences/specialties in a particular group of congenital heart defects? • Are there any causes that underlie these restrictions (for example Hemodynamics: duration/degree of pulmonary hyper circulation [Qp/Qs]; surgery: Number, age, access route; cyanosis: duration, extent; current lifestyle: daily activity, nicotine abuse, body mass index; current physical abilities: strength in the upper part of the body or in the respiratory muscles, flexibility in the shoulder girdle)? • Do the possible limitations affect the patient (NYHA class / functional class, cardiovascular performance, autonomic nervous system function, general fitness [strength, endurance, speed, coordination, flexibility], quality of life)?	—

Measure

Time frame

• Are there changes in lung function in patients with congenital heart defects? • Are there differences/specialties in a particular group of congenital heart defects? • Are there any causes that underlie these restrictions (for example Hemodynamics: duration/degree of pulmonary hyper circulation [Qp/Qs]; surgery: Number, age, access route; cyanosis: duration, extent; current lifestyle: daily activity, nicotine abuse, body mass index; current physical abilities: strength in the upper part of the body or in the respiratory muscles, flexibility in the shoulder girdle)? • Do the possible limitations affect the patient (NYHA class / functional class, cardiovascular performance, autonomic nervous system function, general fitness [strength, endurance, speed, coordination, flexibility], quality of life)?

—

Secondary

Measure	Time frame
Creation of a register of reference values: it is planned to create a register in which the lung function values of as many patients with congenital heart defects (all age groups, different heart defects, different function classes, etc.) as possible will be collected. This register will then be available within the clinic.	—

Countries

Germany

Contacts

Public ContactJulia Hock

Deutsches Herzzentrum München

hock@dhm.mhn.de+498912183009

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026